ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $128,000 | -28.1% | 26,000 | -22.8% | 0.00% | – |
| Q2 2021 | $178,000 | -41.8% | 33,700 | -47.1% | 0.00% | – |
| Q1 2021 | $306,000 | +10.9% | 63,700 | 0.0% | 0.00% | – |
| Q4 2020 | $276,000 | +5.3% | 63,700 | 0.0% | 0.00% | – |
| Q3 2020 | $262,000 | +21.3% | 63,700 | -24.4% | 0.00% | – |
| Q2 2020 | $216,000 | -12.9% | 84,300 | -1.7% | 0.00% | – |
| Q1 2020 | $248,000 | -5.0% | 85,739 | +24.4% | 0.00% | – |
| Q4 2019 | $261,000 | -13.3% | 68,939 | +17.0% | 0.00% | – |
| Q3 2019 | $301,000 | -17.5% | 58,928 | +0.2% | 0.00% | – |
| Q2 2019 | $365,000 | +305.6% | 58,797 | +366.8% | 0.00% | – |
| Q1 2019 | $90,000 | -15.9% | 12,597 | +0.8% | 0.00% | – |
| Q4 2018 | $107,000 | -68.0% | 12,497 | -25.0% | 0.00% | – |
| Q3 2018 | $334,000 | -21.8% | 16,661 | +0.8% | 0.00% | – |
| Q2 2018 | $427,000 | – | 16,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 984,329 | $6,999,000 | 4.03% |
| Broadfin Capital, LLC | 2,469,894 | $17,561,000 | 3.63% |
| Healthcare Value Capital, LLC | 100,000 | $711,000 | 2.74% |
| ARMISTICE CAPITAL, LLC | 2,744,000 | $19,510,000 | 1.07% |
| DELTEC ASSET MANAGEMENT LLC | 536,836 | $3,817,000 | 0.84% |
| SECTORAL ASSET MANAGEMENT INC | 808,924 | $5,751,000 | 0.69% |
| Mosaic Family Wealth, LLC | 91,314 | $649,000 | 0.26% |
| Worth Venture Partners, LLC | 59,740 | $425,000 | 0.24% |
| EMERALD ADVISERS, LLC | 626,247 | $4,453,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 565,319 | $4,019,000 | 0.16% |